2,3-dihydroxybenzoic acid ( 2,3-dhb ) , a recently identified , orally effective iron-chelating drug , inhibited membrane peroxidation in vitro in h2o2-stressed erythrocytes from patients with beta-thalassaemia major , beta-thalassaemia intermedia , haemoglobin koln disease and sickle cell disease .
C0019045
haemoglobin
C0002895
sickle cell disease